Charles Schwab’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Charles Schwab’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-157,980	Closed	-$22.1M	–	3435
2020 Q3	$22.1M	Buy	157,980 +91,819	+139%	+$11.2M	0.01%	1138
2020 Q2	$4.97M	Sell	66,161 -98,715	-60%	-$5.17M	﹤0.01%	2030
2020 Q1	$4.7M	Buy	164,876 +80,123	+95%	+$2.07M	﹤0.01%	1870
2019 Q4	$2.12M	Buy	84,753 +3,788	+5%	+$90.6K	﹤0.01%	2400
2019 Q3	$1.41M	Buy	+80,965	New	+$2.45M	﹤0.01%	2483

Charles Schwab's LVGO Position: Q4 2020 in Review

Charles Schwab sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 157,980 shares — an estimated $22.1M sold.

Charles Schwab first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $22.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Charles Schwab reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Charles Schwab sold 157,980 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $22.1M.
Charles Schwab first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Charles Schwab's Livongo Health, Inc. Common Stock position peaked at $22.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.